These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20031729)

  • 1. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device.
    Sack S; Kahlert P; Bilodeau L; Pièrard LA; Lancellotti P; Legrand V; Bartunek J; Vanderheyden M; Hoffmann R; Schauerte P; Shiota T; Marks DS; Erbel R; Ellis SG
    Circ Cardiovasc Interv; 2009 Aug; 2(4):277-84. PubMed ID: 20031729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.
    Machaalany J; Bilodeau L; Hoffmann R; Sack S; Sievert H; Kautzner J; Hehrlein C; Serruys P; Sénéchal M; Douglas P; Bertrand OF
    Am Heart J; 2013 May; 165(5):761-9. PubMed ID: 23622913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: first in man experience with a temporary implant.
    Dubreuil O; Basmadjian A; Ducharme A; Thibault B; Crepeau J; Lam JY; Bilodeau L
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1053-61. PubMed ID: 17525965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation).
    Harnek J; Webb JG; Kuck KH; Tschope C; Vahanian A; Buller CE; James SK; Tiefenbacher CP; Stone GW
    JACC Cardiovasc Interv; 2011 Jan; 4(1):115-22. PubMed ID: 21251638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaenous mitral valve: A non-stented coronary sinus device for the treatment of functional mitral regurgitation in heart failure patients.
    Sack S; Kahlert P; Erbel R
    Minim Invasive Ther Allied Technol; 2009; 18(3):156-63. PubMed ID: 19431068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method of percutaneous mitral valve repair for ischemic mitral regurgitation.
    Sorajja P; Nishimura RA; Thompson J; Zehr K
    JACC Cardiovasc Interv; 2008 Dec; 1(6):663-72. PubMed ID: 19463382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leaflet-to-Annuloplasty Ring Clipping for Severe Mitral Regurgitation.
    Kanda BS; Jay D; Farivar RS; Sorajja P
    JACC Cardiovasc Interv; 2016 Apr; 9(7):e63-4. PubMed ID: 26952908
    [No Abstract]   [Full Text] [Related]  

  • 8. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus.
    Webb JG; Harnek J; Munt BI; Kimblad PO; Chandavimol M; Thompson CR; Mayo JR; Solem JO
    Circulation; 2006 Feb; 113(6):851-5. PubMed ID: 16461812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous mitral annuloplasty with the VIACOR coronary sinus system for the treatment of functional mitral regurgitation in heart failure patients. Development and results].
    Sack S
    Herz; 2009 Sep; 34(6):468-76. PubMed ID: 19784565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System.
    Nickenig G; Hammerstingl C; Schueler R; Topilsky Y; Grayburn PA; Vahanian A; Messika-Zeitoun D; Urena Alcazar M; Baldus S; Volker R; Huntgeburth M; Alfieri O; Latib A; La Canna G; Agricola E; Colombo A; Kuck KH; Kreidel F; Frerker C; Tanner FC; Ben-Yehuda O; Maisano F
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2039-2047. PubMed ID: 27712741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty.
    Bouleti C; Fassa AA; Himbert D; Brochet E; Ducrocq G; Nejjari M; Ghodbane W; Depoix JP; Nataf P; Vahanian A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):83-91. PubMed ID: 25616821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Year Outcomes After Transcatheter Mitral Valve Replacement.
    Regueiro A; Ye J; Fam N; Bapat VN; Dagenais F; Peterson MD; Windecker S; Webb JG; Rodés-Cabau J
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1671-1678. PubMed ID: 28838478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter Procedure for Residual Mitral Regurgitation After MitraClip Implantation Using Amplatzer Duct Occluder II.
    Kubo S; Cox JM; Mizutani Y; Uberoi A; Chakravarty T; Nakajima Y; Hussaini A; Tat E; Makar M; Kar S
    JACC Cardiovasc Interv; 2016 Jun; 9(12):1280-1288. PubMed ID: 27339846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults.
    Cullen MW; Cabalka AK; Alli OO; Pislaru SV; Sorajja P; Nkomo VT; Malouf JF; Cetta F; Hagler DJ; Rihal CS
    JACC Cardiovasc Interv; 2013 Jun; 6(6):598-605. PubMed ID: 23683739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter direct mitral valve annuloplasty: a brief review.
    Feldman T; Guerrero M
    EuroIntervention; 2015 Sep; 11 Suppl W():W53-7. PubMed ID: 26384191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience.
    Palacios IF; Condado JA; Brandi S; Rodriguez V; Bosch F; Silva G; Low RI; Rogers JH
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):513-8. PubMed ID: 17323357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty.
    Maniu CV; Patel JB; Reuter DG; Meyer DM; Edwards WD; Rihal CS; Redfield MM
    J Am Coll Cardiol; 2004 Oct; 44(8):1652-61. PubMed ID: 15489099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Dimensional Echocardiography Compared With Computed Tomography to Determine Mitral Annulus Size Before Transcatheter Mitral Valve Implantation.
    Mak GJ; Blanke P; Ong K; Naoum C; Thompson CR; Webb JG; Moss R; Boone R; Ye J; Cheung A; Munt B; Leipsic J; Grewal J
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27307549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study.
    Lim DS; Kar S; Spargias K; Kipperman RM; O'Neill WW; Ng MKC; Fam NP; Walters DL; Webb JG; Smith RL; Rinaldi MJ; Latib A; Cohen GN; Schäfer U; Marcoff L; Vandrangi P; Verta P; Feldman TE
    JACC Cardiovasc Interv; 2019 Jul; 12(14):1369-1378. PubMed ID: 31255562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcatheter Mitral Valve Implantation With the FORTIS Device: Insights Into the Evaluation of Device Success.
    Abdul-Jawad Altisent O; Dumont E; Dagenais F; Sénéchal M; Bernier M; O'Connor K; Paradis JM; Bilodeau S; Pasian S; Rodés-Cabau J
    JACC Cardiovasc Interv; 2015 Jun; 8(7):994-5. PubMed ID: 26003029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.